CIK 0002020932 · Non-accelerated filer<br>Emerging growth company
AgomAb Therapeutics NV
Sign in to watch- Ticker
- AGMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Belgium
- Entity type
- other
- Phone
- 32 3 302 35 30
- Business address
- POSTHOFLEI 1/6, ANTWERPEN, Belgium, 2600
- Open-market buys, last 90 days
- $503,470
- in 6 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$503,470. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-05 | Epstein David R Director | Purchase | +5,000 | $6.81 | $34K | 30,000 |
| 2026-11-05 | Epstein David R Director | Purchase | +5,000 | $6.91 | $35K | 35,000 |
| 2026-11-05 | Epstein David R Director | Purchase | +5,000 | $6.98 | $35K | 40,000 |
| 2026-10-21 | Epstein David R Director | Purchase | +5,000 | $8.86 | $44K | 20,000 |
| 2026-10-21 | Epstein David R Director | Purchase | +5,000 | $8.90 | $45K | 25,000 |
| 2026-10-08 | Epstein David R Director | Purchase | +5,000 | $8.90 | $45K | 15,000 |
| 2026-10-06 | Knotnerus Tim Jasper Chief Executive Officer | Purchase | +5,000 | $8.70 | $44K | 21,823 |
| 2026-10-06 | Kemula Pierre Thadee Victor Chief Financial Officer | Purchase | +3,000 | $8.67 | $26K | 3,000 |
| 2026-10-06 | Kemula Pierre Thadee Victor Chief Financial Officer | Purchase | +5,000 | $8.57 | $43K | 8,000 |
| 2026-10-06 | Kemula Pierre Thadee Victor Chief Financial Officer | Purchase | +2,000 | $8.54 | $17K | 10,000 |
| 2026-10-06 | Epstein David R Director | Purchase | +5,000 | $8.70 | $44K | 10,000 |
| 2026-10-05 | Knotnerus Tim Jasper Chief Executive Officer | Purchase | +6,000 | $8.48 | $51K | 16,823 |
| 2026-10-05 | Epstein David R Director | Purchase | +5,000 | $8.57 | $43K | 5,000 |
| 2026-09-11 | Garcia Marino Director | Grant or award · Stock Option (Right to Buy) | +57,482 | 57,482 | ||
| 2026-09-11 | Patel Naimish Director | Grant or award · Stock Option (Right to Buy) | +56,328 | 56,328 |
Page 1 of 1 · 15 trades